Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The study, recently presented at the European Congress on Obesity in Istanbul, Turkey, from May 1215, has not yet been published in a peer-reviewed journal
PT-141 (bremelanotide, brand name Vyleesi) is a melanocortin receptor agonist FDA-approved for treating hypoactive sexual desire disorder (HSDD) in premenopausal women
If your Clinician decides medication is right for you, they'll write a prescription and your Care Team will work with your insurance to minimize out-of-pocket costs
No medical claims are made or implied for any product and these are being sold as Nutritional/Dietary Supplements
Pricing can vary based on the pharmacy, your prescribed dosage, and whether you are able to utilize manufacturer savings programs or pharmacy discount cards
